American Hospital Formulary Service, American Society of Hospital Pharmacists, Washington, D. C. (R).
5.
ArterberryJ. D.: Potentiation of Phosphorous Insecticides by Phenothiazine Derivatives, J. Am. Med. Assoc.182: 848 (Nov. 24) 1962 (CH).
6.
BridenbaughP. O.Churchill-DavidsonH. C.: Response to Tubocurarine Chloride and Its Reversal by Neostigmine Methylsulfate in Man, ibid.203: 541 (Feb. 19) 1968 (OH).
7.
BrodieB. B.: Displacement of One Drug by Another from Carrier or Receptor Sites, Proc. Roy. Soc. Med.58: 946 (Nov.) 1965 (R).
8.
ChristensenE. M.GrossE. G.: Analgesic Effects in Human Subjects of Morphine, Meperidine, and Methadone, J. Am. Med. Assoc.137: 594 (June 12) 1948 (OH).
9.
DrackmanD. A.SkomJ. H.: Procainamide — A Hazard in Myasthenia Gravis, Arch. Neurol.13: 316 (Sept.) 1965 (CH).
10.
EllisP. P.EsterdahlM.: Echothiophate Iodine Therapy in Children, Effect Upon Blood Cholinesterase Levels, Arch. Ophthalmol.77: 598 (May) 1967 (H).
11.
FormanD. T.: Effect of Variables on Chemical and Diagnostic Specificity of Laboratory Tests, Memo to Medical Staff, Evanston Hospital (R).
12.
GoodmanL. S.GilmanA.: The Pharmacological Basis of Therapeutics, Macmillan Co., New York, 1965, p. 1277.
13.
HartshornE. A.: Drug Interactions II. How Drugs Interact, Drug Intelligence2: 58 (Mar.) 1968 (R).
McIverA. K., Incompatibilities, Pharm. J.199: 205, 1967 (R).
16.
MiddletonW. H.MorganD. C.MoyersJ.: Neostigmine Therapy for Apnea Occurring after Administration of Neomycin, J. Am. Med. Assoc.165: 2186 (Dec. 28) 1957 (CH).
17.
MorrelliH. F.MelmonK. L.: The Clinician's Approach to Drug Interactions, Calif. Med.109: 380 (Nov.) 1968 (R).
18.
McGaviD. D. Murray: Depressed Levels of Serum-Pseudocholinesterase with Ecothiophate Iodine Eye Drops, Lancet2: 272 (Aug. 7) 1965 (CH).
19.
ReamC. R.: Respiratory and Cardiac Arrest After Intravenous Administration of Kanamycin with Reversal of Toxic Effects by Neostigmine, Ann. Internal Med.59: 384 (Sept.) 1963 (CH).
20.
SabawalaP. B.DillonJ. B.: The Action of Some Antibiotics on the Human Intercostal Nerve-Muscle Complex, Anesthesiology20: 659 (Sept.-Oct.) 1959 (OT).
21.
SeyboldR.BrautigamK. H.: Prolonged Suc-cinyl-Induced Apnea as an Indication of Alkylphosphate Poisoning, Deut. Med. Wochschr.93: 1405–1406 (July 19) 1968 (CH).
22.
SikhS. S.SachdovK. S.: Duration of the Neuromuscular Blocking Action of Streptomycin, Brit. J. Anaesthesiol.37: 158 (Mar.) 1965 (OA).
23.
SlaughterD.MunsellD. W.: Some New Aspects of Morphine Action: Effects on Pain, J. Pharmacol. Exptl. Therap.68: 104 (Jan.) 1940 (OA).
24.
StuartD. M.: Drug Metabolism. Part II. Drug Interaction, pharmIndex10: 4 (Oct.) 1968 (R).
25.
BurgerH.: Drugs Affecting the Central Nervous System, Vol. 2, New York, 1968Marcel-Dekker, Inc.
26.
PretiM.Della BellaD.: Influence of Certain Drugs on the Acute Toxicity of Specific Antibiotics, Boll. Chim. Farm.106: 603 (Sept.) 1967 (OAT).
27.
ProctorC. D.DenefieldB. A.AshleyL. G.: Extension of Ethyl Alcohol Action by Pilocarpine, Brain Res.3: 217–20 (Dec.) 1966.
28.
WullenF.KastG.BruckA.: Side Effects of Tetracycline Administration in Patients with Myasthenia Gravis, Deut. Med. Wochschr.92: 667 (Apr. 7) 1967 (CH).